These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6200026)

  • 1. A role of alpha-fetoprotein in autoimmune diseases.
    Abramsky O; Brenner T
    Ann N Y Acad Sci; 1983; 417():108-16. PubMed ID: 6200026
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression of experimental autoimmune myasthenia gravis by alpha-fetoprotein rich formation.
    Brenner T; Abramsky O
    Immunol Lett; 1981 Aug; 3(3):163-7. PubMed ID: 6169635
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein-rich fractions.
    Brenner T; Zielinski A; Argov Z; Abramsky O
    Tumour Biol; 1984; 5(5):263-74. PubMed ID: 6085187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation in experimental autoimmune myasthenia gravis.
    De Baets MH; Einarson B; Lindstrom JM; Weigle WO
    J Immunol; 1982 May; 128(5):2228-35. PubMed ID: 6977589
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hypothalamic lesions on experimental autoimmune diseases in rats.
    Abramsky O; Wertman E; Reches A; Brenner T; Ovadia H
    Ann N Y Acad Sci; 1987; 496():360-5. PubMed ID: 2440369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein suppresses experimental allergic encephalomyelitis.
    Abramsky O; Brenner T; Mizrachi R; Soffer D
    J Neuroimmunol; 1982 Jan; 2(1):1-7. PubMed ID: 6185533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
    Abramsky O; Brenner T
    Isr J Med Sci; 1979 Nov; 15(11):943-5. PubMed ID: 93589
    [No Abstract]   [Full Text] [Related]  

  • 9. alpha-Fetoprotein and neonatal transient myasthenia gravis.
    Heininger K; Edler C; Toyka KV
    Neurology; 1984 Mar; 34(3):403-4. PubMed ID: 6199689
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis.
    Zurn AD; Fulpius BW
    Eur J Immunol; 1977 Aug; 7(8):529-32. PubMed ID: 902680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
    Claudio T; Raftery MA
    J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity to myelin basic protein.
    Swanborg RH; Holda JH; Killen JA
    Adv Exp Med Biol; 1982; 150():3-22. PubMed ID: 6183945
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1983 Mar; 51(3):543-50. PubMed ID: 6851245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity to cell membrane receptors.
    De Baets MH; van Breda Vriesman PJ
    Surv Synth Pathol Res; 1985; 4(3):185-215. PubMed ID: 3008292
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors in the production of experimental autoimmune myasthenia gravis in acetylcholine receptor immunized rabbits.
    Niemi WD; Nastuk WL; Chang HW; Plescia OJ; Plescia AM
    Ann N Y Acad Sci; 1981; 377():222-36. PubMed ID: 6951475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postsynapic membrane of Torpedo electroplax: acetylcholine receptor localization and its use as a tool in the study of cellular immuninty in myasthenia gravis.
    Conti-Tronconi B; Morgutti M; Gotti C; Clementi F
    Adv Cytopharmacol; 1979; 3():255-67. PubMed ID: 382788
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of experimental autoimmune myasthenia gravis by recombinant fragments of the human acetylcholine receptor.
    Souroujon MC; Barchan D; Fuchs S
    Ann N Y Acad Sci; 1998 May; 841():572-5. PubMed ID: 9668298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.